Identification of TNFAIP6 as a hub gene associated with the progression of glioblastoma by weighted gene co-expression network analysis.
Journal
IET systems biology
ISSN: 1751-8857
Titre abrégé: IET Syst Biol
Pays: England
ID NLM: 101301198
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
29
05
2022
received:
17
08
2021
accepted:
08
06
2022
pubmed:
30
6
2022
medline:
16
9
2022
entrez:
29
6
2022
Statut:
ppublish
Résumé
This study aims to discover the genetic modules that distinguish glioblastoma multiforme (GBM) from low-grade glioma (LGG) and identify hub genes. A co-expression network is constructed using the expression profiles of 28 GBM and LGG patients from the Gene Expression Omnibus database. The authors performed gene ontology (GO) and Kyoto encyclopaedia of genes and genomes (KEGG) analysis on these genes. The maximal clique centrality method was used to identify hub genes. Online tools were employed to confirm the link between hub gene expression and overall patient survival rate. The top 5000 genes with major variance were classified into 18 co-expression gene modules. GO analysis indicated that abnormal changes in 'cell migration' and 'collagen metabolic process' were involved in the development of GBM. KEGG analysis suggested that 'focal adhesion' and 'p53 signalling pathway' regulate the tumour progression. TNFAIP6 was identified as a hub gene, and the expression of TNFAIP6 was increased with the elevation of pathological grade. Survival analysis indicated that the higher the expression of TNFAIP6, the shorter the survival time of patients. The authors identified TNFAIP6 as the hub gene in the progression of GBM, and its high expression indicates the poor prognosis of the patients.
Identifiants
pubmed: 35766985
doi: 10.1049/syb2.12046
pmc: PMC9469790
doi:
Substances chimiques
Cell Adhesion Molecules
0
TNFAIP6 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
145-156Informations de copyright
© 2022 The Authors. IET Systems Biology published by John Wiley & Sons Ltd on behalf of The Institution of Engineering and Technology.
Références
Brain Pathol. 2010 Jan;20(1):245-54
pubmed: 19903171
Sci Rep. 2019 Jul 22;9(1):10555
pubmed: 31332251
Cancer Res. 2009 Oct 1;69(19):7569-76
pubmed: 19773441
J Biol Chem. 2016 Sep 16;291(38):19939-52
pubmed: 27435674
Neurology. 2017 Apr 11;88(15):1422-1430
pubmed: 28298550
Neurobiol Dis. 2013 Nov;59:86-99
pubmed: 23851308
Biochem Biophys Res Commun. 2001 Sep 14;287(1):173-80
pubmed: 11549271
Aging (Albany NY). 2019 Dec 17;11(24):12246-12269
pubmed: 31844032
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Biomaterials. 2020 Feb;232:119677
pubmed: 31865193
BMC Syst Biol. 2014;8 Suppl 4:S11
pubmed: 25521941
Int J Biochem Cell Biol. 2004 Jun;36(6):1046-69
pubmed: 15094120
PLoS One. 2015 Aug 19;10(8):e0136026
pubmed: 26288013
BMC Med Genomics. 2019 Mar 20;11(Suppl 7):34
pubmed: 30894197
Cytotherapy. 2018 Feb;20(2):218-231
pubmed: 29223534
Clin Cancer Res. 2016 Oct 1;22(19):4797-4806
pubmed: 27143690
Aging (Albany NY). 2019 Sep 3;11(17):6930-6940
pubmed: 31479417
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Neuro Oncol. 2013 Oct;15(10):1317-29
pubmed: 23814263
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Br J Cancer. 2013 Nov 26;109(11):2853-63
pubmed: 24169356
J Neurosurg. 2004 Mar;100(3):523-33
pubmed: 15035290
Mol Ther. 2017 Jul 5;25(7):1544-1555
pubmed: 28109960
Clin Transl Oncol. 2009 Nov;11(11):711-4
pubmed: 19917533
Eur J Cancer. 2012 Sep;48(14):2192-202
pubmed: 22608262
Nucleic Acids Res. 2015 Jan;43(Database issue):D1049-56
pubmed: 25428369
Mol Cell Biol. 2013 Apr;33(7):1394-409
pubmed: 23339869
IET Syst Biol. 2022 Sep;16(5):145-156
pubmed: 35766985
Mol Genet Genomics. 2020 May;295(3):741-749
pubmed: 32125527
Histochem Cell Biol. 2018 Mar;149(3):235-244
pubmed: 29322326
Cancer Res. 2006 Sep 15;66(18):9074-82
pubmed: 16982749
Diabetes. 2013 Jun;62(6):2048-58
pubmed: 23349496
Cancers (Basel). 2019 Mar 13;11(3):
pubmed: 30871240
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100
pubmed: 31675094
JAMA. 2015 Dec 15;314(23):2535-43
pubmed: 26670971
Neuro Oncol. 2018 Sep 3;20(10):1310-1320
pubmed: 29660021
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
J Exp Clin Cancer Res. 2016 Apr 02;35:61
pubmed: 27039073
J Clin Oncol. 2005 Apr 1;23(10):2411-22
pubmed: 15800333
Arch Biochem Biophys. 2017 Jun 1;623-624:1-8
pubmed: 28137422
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Ann Transl Med. 2019 Dec;7(24):800
pubmed: 32042816
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Front Physiol. 2019 Aug 20;10:1081
pubmed: 31481902
Sci Rep. 2016 Dec 05;6:38438
pubmed: 27917949
Lancet Oncol. 2017 Oct;18(10):1373-1385
pubmed: 28844499
Front Biosci. 1996 Nov 01;1:d324-39
pubmed: 9159237
PLoS One. 2016 Jan 21;11(1):e0147553
pubmed: 26793973
J Cell Sci. 2003 May 15;116(Pt 10):1863-73
pubmed: 12692188
J Leukoc Biol. 2009 Jul;86(1):123-32
pubmed: 19389798
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Mol Cell Biol. 1990 May;10(5):1982-8
pubmed: 2183014